Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Determinants of the extent and duration of STAT3 signaling.

Groner B.

JAKSTAT. 2012 Jul 1;1(3):211-5. doi: 10.4161/jkst.21469.

3.

Somatic STAT3 mutations in large granular lymphocytic leukemia.

Koskela HL, Eldfors S, Ellonen P, van Adrichem AJ, Kuusanmäki H, Andersson EI, Lagström S, Clemente MJ, Olson T, Jalkanen SE, Majumder MM, Almusa H, Edgren H, Lepistö M, Mattila P, Guinta K, Koistinen P, Kuittinen T, Penttinen K, Parsons A, Knowles J, Saarela J, Wennerberg K, Kallioniemi O, Porkka K, Loughran TP Jr, Heckman CA, Maciejewski JP, Mustjoki S.

N Engl J Med. 2012 May 17;366(20):1905-13. doi: 10.1056/NEJMoa1114885.

4.

Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia.

Teramo A, Gattazzo C, Passeri F, Lico A, Tasca G, Cabrelle A, Martini V, Frezzato F, Trimarco V, Ave E, Boscaro E, Piazza F, Facco M, Trentin L, Semenzato G, Zambello R.

Blood. 2013 May 9;121(19):3843-54, S1. doi: 10.1182/blood-2012-07-441378. Epub 2013 Mar 20.

6.

Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.

Zhang Q, Lee B, Korecka M, Li G, Weyland C, Eck S, Gessain A, Arima N, Lessin SR, Shaw LM, Luger S, Kamoun M, Wasik MA.

Leuk Res. 1999 Apr;23(4):373-84.

PMID:
10229324
7.

JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.

Song L, Rawal B, Nemeth JA, Haura EB.

Mol Cancer Ther. 2011 Mar;10(3):481-94. doi: 10.1158/1535-7163.MCT-10-0502. Epub 2011 Jan 7.

8.

Engagement of T-cell antigen receptor and CD4/CD8 co-receptors induces prolonged STAT activation through autocrine/paracrine stimulation in human primary T cells.

Chueh FY, Yu CL.

Biochem Biophys Res Commun. 2012 Sep 21;426(2):242-6. doi: 10.1016/j.bbrc.2012.08.074. Epub 2012 Aug 23.

9.
11.
13.

Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.

Rajala HL, Porkka K, Maciejewski JP, Loughran TP Jr, Mustjoki S.

Ann Med. 2014 May;46(3):114-22. doi: 10.3109/07853890.2014.882105. Epub 2014 Feb 11. Review.

PMID:
24512550
14.

IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells.

Kopantzev Y, Heller M, Swaminathan N, Rudikoff S.

Oncogene. 2002 Oct 3;21(44):6791-800.

15.

Activation of the Jak-STAT-signaling pathway in embryonic lens cells.

Potts JD, Kornacker S, Beebe DC.

Dev Biol. 1998 Dec 1;204(1):277-92.

16.

Arsenic inhibition of the JAK-STAT pathway.

Cheng HY, Li P, David M, Smithgall TE, Feng L, Lieberman MW.

Oncogene. 2004 Apr 29;23(20):3603-12.

PMID:
15116095
17.

Identification of canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the intracellular domain of the interleukin 23 receptor.

Floss DM, Mrotzek S, Klöcker T, Schröder J, Grötzinger J, Rose-John S, Scheller J.

J Biol Chem. 2013 Jul 5;288(27):19386-400. doi: 10.1074/jbc.M112.432153. Epub 2013 May 14.

18.

Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells.

Duechting A, Tschöpe C, Kaiser H, Lamkemeyer T, Tanaka N, Aberle S, Lang F, Torresi J, Kandolf R, Bock CT.

J Virol. 2008 Aug;82(16):7942-52. doi: 10.1128/JVI.00891-08. Epub 2008 Jun 11.

19.

"Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.

Trilling M, Le VT, Rashidi-Alavijeh J, Katschinski B, Scheller J, Rose-John S, Androsiac GE, Jonjic S, Poli V, Pfeffer K, Hengel H.

J Immunol. 2014 Jan 1;192(1):447-58. doi: 10.4049/jimmunol.1203516. Epub 2013 Dec 6.

Supplemental Content

Support Center